Fundraising Fox
Adam M. Koppel
InvestorPartner at Bain Capital Life Sciences · Board director at Areteia Therapeutics · Board director at Cardurion Pharmaceuticals, Inc. · Board director at Solid Biosciences
Boston
Writes $100K – $5M checks · typically $1.5M
Find your path to Adam
808 people in our graph can introduce you to Adam.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Seth Glickman to introduce you to Adam
You →Seth · together at University of Pennsylvania School of Medicine (1996–1999) →Adam
Ask Jamie Chen to introduce you to Adam
You →Jamie · 2 people · together at University of Pennsylvania School of Medicine →Adam
Ask Sam Okafor to introduce you to Adam
You →Sam · 7 people · together at McKinsey & Company →Adam
Sign up to find every way you can get introduced to Adam
- Your email: the people you already email who know Adam
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Adam
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Adam M. Koppel is a Partner on the Life Sciences team at Bain Capital, which he first joined in 2003 and rejoined in 2016, having earlier been part of the firm's Public Equity team focused on healthcare. Between his stints at Bain Capital, he served as EVP of Corporate Development and Chief Strategy Officer at Biogen, and prior to that was an Associate Principal at McKinsey & Company. He holds an MD and PhD in neuroscience and an MBA from the University of Pennsylvania, and an AB and AM in history and science from Harvard University.
Invests in
Biotech
Board director at Areteia Therapeutics
Intro paths
In turn, Adam can intro founders to Areteia Therapeutics's investors below.
Areteia Therapeutics's investors · 10
Board director at Cardurion Pharmaceuticals, Inc.
Intro paths
In turn, Adam can intro founders to Cardurion Pharmaceuticals, Inc.'s investors below.
Cardurion Pharmaceuticals, Inc.'s investors · 6
Board director at Solid Biosciences
Intro paths
In turn, Adam can intro founders to Solid Biosciences's investors below.
Solid Biosciences's investors · 4
Co-founders at Solid Biosciences
Experience
- Bain CapitalManaging Directorcurrent2016 — presentBoston, MA
- BiogenEVP, Corporate Development & Strategy2014 — 2016Cambridge, MA
- Bain CapitalManaging Director2003 — 2014
- McKinsey & CompanyAssociate Principal2000 — 2004
Skills & more
+8 more
HealthcareFinancial ModelingStart-upsHedge FundsEquity ResearchPortfolio ManagementCompetitive AnalysisPharmaceutical IndustryFrom Adam's professional profile.
Deals · 4
Areteia TherapeuticsBoard seat
via Bain Capital Life Sciences · filed Feb 2025 · $445M raise
Cardurion Pharmaceuticals, Inc.Board seat
via Bain Capital Life Sciences · filed Jul 2023 · $128.1M raise
Solid BiosciencesBoard seat
via Bain Capital Life Sciences · filed Oct 2020 · $40M raise
AptinyxBoard seat
via Bain Capital Life Sciences · filed Dec 2017 · $70M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Cerevel TherapeuticsInflaRxPTC TherapeuticsSynapticureViaCyte
Sources: SEC Form D filings · curated public sources.
Colleagues at Bain Capital Life Sciences
Network7
Investors connected to Adam in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Adam M. Koppel?
- Adam M. Koppel is a Partner on the Life Sciences team at Bain Capital, which he first joined in 2003 and rejoined in 2016, having earlier been part of the firm's Public Equity team focused on healthcare. Between his stints at Bain Capital, he served as EVP of Corporate Development and Chief Strategy Officer at Biogen, and prior to that was an Associate Principal at McKinsey & Company. He holds an MD and PhD in neuroscience and an MBA from the University of Pennsylvania, and an AB and AM in history and science from Harvard University.
- Where does Adam M. Koppel work?
- Adam M. Koppel is Partner at Bain Capital Life Sciences and Board director at Areteia Therapeutics and Board director at Cardurion Pharmaceuticals, Inc. and Board director at Solid Biosciences.
- What does Adam M. Koppel invest in?
- Adam M. Koppel invests in Biotech.
- What check size does Adam M. Koppel write?
- Adam M. Koppel typically writes checks of $100K – $5M.
- What boards does Adam M. Koppel sit on?
- Adam M. Koppel holds tracked board seats at Aptinyx, Areteia Therapeutics, Cardurion Pharmaceuticals, Inc., Solid Biosciences.
- What companies has Adam M. Koppel invested in?
- Investments tracked here include Aptinyx, Areteia Therapeutics, Cerevel Therapeutics, InflaRx, PTC Therapeutics, Solid Biosciences, Synapticure, ViaCyte.
- Where did Adam M. Koppel go to school?
- Adam M. Koppel studied at Harvard University; University of Pennsylvania School of Medicine (MD, PhD); The Wharton School (MBA, Finance).
Same school
Also attended Harvard University2,000
+ 1,994 more
Also attended University of Pennsylvania School of Medicine56
+ 50 more
Also attended The Wharton School2,000
+ 1,994 more
Shared employers
Also worked at Biogen99
+ 93 more
Also worked at Bain Capital289
+ 283 more
Also worked at McKinsey & Company2,000
+ 1,994 more